4,800 People Waited for Hours in the Rain to See if They Were Eligible Stem Cell Donors for Little Boy with Rare Leukemia

On December 28, 2018, five-year-old Oscar Saxelby-Lee was diagnosed with a rare and aggressive form of leukemia. Now he's in a race against time to find an eligible stem cell…

Continue Reading 4,800 People Waited for Hours in the Rain to See if They Were Eligible Stem Cell Donors for Little Boy with Rare Leukemia
Investigational Drug for Charcot-Marie-Tooth Disease Earns Orphan Drug Designation
NeuPaddy / Pixabay

Investigational Drug for Charcot-Marie-Tooth Disease Earns Orphan Drug Designation

According to a story from Central Charts, the biopharmaceutical company Acceleron Pharma Inc. recently announced that the company's experimental drug candidate ACE-083 has earned Orphan Drug designation from the US…

Continue Reading Investigational Drug for Charcot-Marie-Tooth Disease Earns Orphan Drug Designation

Study Testing Gene Therapy for Charcot-Marie-Tooth Disease Earns Funding from MDA and CMTA

According to a story from The Muscular Dystrophy Association (MDA), the organization alongside the Charot-Marie-Tooth Association (CMTA) has awarded grant funding totaling $276,430 to a research study that will develop…

Continue Reading Study Testing Gene Therapy for Charcot-Marie-Tooth Disease Earns Funding from MDA and CMTA

New Resources Could Improve Drug Development for Fibrodysplasia Ossificans Progressiva

Ipsen has just announced that they will be acquiring Clementia Pharmaceuticals. This merging of companies is exciting for the rare community because it will strengthen the resources, knowledge-base, and overall…

Continue Reading New Resources Could Improve Drug Development for Fibrodysplasia Ossificans Progressiva

Updates From Spark Highlight the Potential of Gene Therapy for Treating Hemophilia

According to a story from Hemophilia News Today, the drug developer Spark Therapeutics, Inc., has recently released several updates in regards to a number of its experimental gene therapies that…

Continue Reading Updates From Spark Highlight the Potential of Gene Therapy for Treating Hemophilia

Phase 1b Trial for Lupus Nephritis Utilizing New Therapeutic Approach to Commence Soon

Lupus Nephritis Lupus nephritis (LN) is one of the most common complications of systemic lupus erythematosus (SLE). It affects approximately 100,000 patients in the United States alone. Basically, the patient's…

Continue Reading Phase 1b Trial for Lupus Nephritis Utilizing New Therapeutic Approach to Commence Soon